AriBio drug AR1001 slows cognitive decline in early Alzheimer’s
AriBio's AR1001 trial shows a 31% reduction in cognitive decline for patients with early Alzheimer's disease. The once-a-day oral tablet increases blood flow to…
Menu
Topic
AriBio's AR1001 trial shows a 31% reduction in cognitive decline for patients with early Alzheimer's disease. The once-a-day oral tablet increases blood flow to…